Discontinued — last reported Q2 '23
Business Segments · Operating Income (Loss)
Pharmaceutical — Operating Income (Loss)
Johnson & Johnson Pharmaceutical — Operating Income (Loss) increased by 9.4% to $4.86B in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 10.0%, from $4.42B to $4.86B. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2009
Last reportedQ2 2023
Rolls up toOperating Income
How to read this metric
Higher operating income reflects efficient cost management and strong product margins, whereas lower income indicates rising operational costs or pricing pressure.
Detailed definition
This is the profit or loss generated by the pharmaceutical segment after deducting operating expenses from net sales. It...
Peer comparison
Standard metric across the industry, often referred to as 'Segment Operating Profit'.
Metric ID:
jnj_segment_pharmaceutical_operating_income_lossHistorical Data
7 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|
| Value | $4.36B | $4.26B | $3.92B | $4.42B | $4.25B | $4.44B | $4.86B |
| QoQ Change | — | -2.2% | -7.9% | +12.6% | -3.9% | +4.6% | +9.4% |
| YoY Change | — | — | — | +1.5% | -0.2% | +13.3% | +10.0% |
Range$3.92B – $4.86B
CAGR+7.6%
Avg YoY Growth+6.1%
Median YoY Growth+5.7%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's pharmaceutical — operating income (loss)?
- Johnson & Johnson (JNJ) reported pharmaceutical — operating income (loss) of $4.86B in Q2 2023.
- How has Johnson & Johnson's pharmaceutical — operating income (loss) changed year-over-year?
- Johnson & Johnson's pharmaceutical — operating income (loss) increased by 10.0% year-over-year, from $4.42B to $4.86B.
- What does pharmaceutical — operating income (loss) mean?
- The profit or loss earned from pharmaceutical operations before interest and taxes.